Teva Active Pharmaceutical Ingredients
R Ananthanarayanan, PhD, currently serves as the Chief Executive Officer at Teva Active Pharmaceutical Ingredients since November 2023. Prior to this role, R Ananthanarayanan was the Whole-Time Director and Chief Executive Officer at Sajjan India Ltd from May 2022 to November 2023 and held the position of Managing Director and Chief Executive Officer at Strides from January 2020 to March 2022. R Ananthanarayanan's extensive experience also includes serving as President and Global Chief Operating Officer at Cipla, President and CEO of Teva API & Biologics, and President at Dr. Reddy's Laboratories. R Ananthanarayanan has a strong background in the pharmaceutical sector with previous roles at Piramal Enterprises Limited, Galpharm International, and Zydus Cadila. R Ananthanarayanan holds a Ph.D. and a B.S. in Pharmaceutical Sciences from the University of Mumbai.
This person is not in any teams
This person is not in any offices
Teva Active Pharmaceutical Ingredients
Teva api is the leading international supplier of active pharmaceutical ingredients (APIs). With the industry's broadest portfolio including over 350 API products, Teva api is the go-to global supplier for APIs, supporting 80% of top 50 global pharmaceutical companies. Teva api has a reliable history in the generic API industry dating back over 80 years, and is considered to be one of the most trusted API suppliers, which enables Teva api to lead the industry, based on our experience, expertise, technologies, and exceptional customer service. Headquartered in Israel, Teva api employs more than 4,000 professionals at 14 sites worldwide. Teva api's state-of-the-art production facilities are located in Italy, Hungary, the Czech Republic, Croatia, Israel, Mexico and India. Teva api provides superior product quality and excellent customer service. Our significant ongoing investment in R&D generates a steady flow of APIs, enabling timely introduction of new products to market. In recent years, we’ve expanded our capabilities in peptide development and manufacturing, while building expertise on single and double-stranded oligonucleotides. The large R&D group comprises over 500 world-class scientists located in six development centers. Our dedicated professionals specialize in the fields of chemical synthesis, fermentation, high potency APIs, plant extraction, synthetic peptides and oligonucleotides, vitamins and prostaglandins, metal organic complexes, inorganic molecules and polymers, with excellence in analytical and solid-state R&D. In case you are looking for a trusted, reliable and professional API partner that will go hand-in-hand with you, from selection all the way to commercial, please feel free to visit our website - www.teva-api.com, or contact us at - https://www.teva-api.com/#contact